アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

b & s healthcare - candesartan cilexetil - tablets - 4 milligram - angiotensin ii antagonists, plain

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

pco manufacturing ltd. - candesartan cilexetil; hydrochlorothiazide - tablet - 16 mg/12.5 milligram(s) - candesartan and diuretics

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

bryant ranch prepack - candesartan cilexetil (unii: r85m2x0d68) (candesartan - unii:s8q36md2xx), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - candesartan cilexetil 32 mg - atacand hct is indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with atacand hct. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blo